Mml Investors Services, LLC Lipocine Inc. Transaction History

Mml Investors Services, LLC

  • $27.4 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
BUY
$0.99 - $1.2 $24,750 - $30,000
25,000 Added 48.08%
77,000 $76,000
Q3 2021

Nov 15, 2021
BUY
$1.08 - $1.49 $6,480 - $8,940
6,000 Added 13.04%
52,000 $57,000
Q2 2021

Aug 13, 2021
BUY
$1.17 - $1.59 $5,850 - $7,950
5,000 Added 12.2%
46,000 $64,000
Q1 2021

May 14, 2021
BUY
$1.38 - $2.28 $56,579 - $93,479
41,000 New
41,000 $62,000

About Lipocine Inc.

LPCN Quotes by TradingView
  • Ticker LPCN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 88,510,800
  • Market Cap $310M
  • Description
  • Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone rep...
More about LPCN
Track This Portfolio

Track Mml Investors Services, LLC Portfolio

Follow Mml Investors Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mml Investors Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mml Investors Services, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email